Atlas Trials

A Thorough QT Study of Telotristat Etiprate

Clinical trial NCT02155205 · COMPLETED

Trial details

NCT number
NCT02155205
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
QT Interval
Start date
2014-05-01
Primary completion
2014-08-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.